Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Breast Neoplasms"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&page=9
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&page=9
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&page=9
PubPharm (10.270)
81
Efficacy and Safety of Ribociclib in Combination With NSAI Versus Physician's Choice of Chemotherapy Sequential Endocrine Therapy in HR+/HER2- Advanced Breast Cancer : Efficacy and Safety of Ribociclib in Combination With NSAI Versus Physician's Choice of Chemotherapy Sequential Endocrine Therapy in HR+/HER2- Advanced Breast Cancer: a Phase II Randomised Controlled Clinical Trial
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
82
Exercise Interventions for Improving Health in Breast Cancer Survivors : Comparing a Technology-enabled, Remotely Delivered Exercise Intervention to Partly-supervised Structured Exercise in Breast Cancer Survivors: a Randomised and Controlled Non- Inferiority Trial
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
83
An Integrated Algorithm for Surgical Intervention in Chronic Lymphedema After Breast Cancer Treatment: The Basel Lymphedema Protocol : An Integrated Algorithm for Surgical Intervention in Chronic Lymphedema After Breast Cancer Treatment: The Basel Lymphedema Protocol
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
84
The Treatment of Stage I and II Carcinoma of the Breast With Mastectomy and Axillary Dissection Versus Excisional Biopsy, Axillary Dissection, and Definitive Irradiation : The Treatment of Stage I and II Carcinoma of the Breast With Mastectomy and Axillary Dissection vs. Excisional Biopsy Axillary Dissection, and Definitive Irradiation
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
85
Study of Palbociclib and Trastuzumab With Endocrine Therapy in HER2-positive Metastatic Breast Cancer : A Phase II Trial of Palbociclib in Combination With Trastuzumab and Endocrine Therapy in Patients With Previously-treated Locally Advanced or Metastatic HER2-positive Breast Cancer (PATRICIA II)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
86
Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer : Phase II Study Of Combination Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
87
Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer : Phase Ib/II Study of Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
88
The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer : A Randomized, Phase II Study Comparing Trastuzumab and Vinorelbine in Combination With Avelumab or Avelumab and Utomilumab (41BB/CD137 Agonist), in Patients With HER2-positive Metastatic Breast Cancer Who Have Progressed on Prior Trastuzumab and Pertuzumab
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
89
DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03] : A Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study of DS-8201a (Trastuzumab Deruxtecan), an Anti-HER2 Antibody Drug Conjugate (ADC), Versus Ado Trastuzumab Emtansine (T-DM1) for HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and Taxane
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
90
ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid Tumors : A Phase 1b Study of ALRN-6924 in Combination With Paclitaxel in Wild-Type TP53 Advanced or Metastatic Solid Tumors Including Estrogen-Receptor Positive Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
[1]
« Vorheriger
4
5
6
7
8
9
10
11
12
13
14
Nächster »
[1027]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Breast Neoplasms
Medienart
10.270
Aufsätze
10.270
E-Artikel
10.270
E-Ressourcen
Zeitschriftentitel
10.270
ClinicalTrials.gov
Thema
Breast Neoplasms
10.269
610
8.085
Study Type: Interventional
4.195
Recruitment Status: Completed
2.500
Medical Condition: Breast Cancer
2.491
Phase: Phase 2
2.352
Recruitment Status: Recruiting
2.104
Study Type: Observational
1.129
Recruitment Status: Active, not recruiting
950
Phase: Phase 3
916
Phase: Phase 1
826
Recruitment Status: Terminated
757
Triple Negative Breast Neoplasms
674
Recruitment Status: Unknown status
623
Recruitment Status: Not yet recruiting
524
Carcinoma
401
Neoplasms
345
Medical Condition: Metastatic Breast Cancer
341
Recruitment Status: Withdrawn
297
Phase: Phase 1, Phase 2
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
6.472
2020-
3.626
2010-2019
172
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
10.270
Englisch
Haven't found what you're looking for?
Wird geladen...